The FDA ensures that the quality of drugs manufactured at the facility is in compliance with cGMP regulation. cGMP compliance includes the implementation of modern quality systems and a robust risk approach that meets the 21 CFR part 210 and 211 of cGMP regulations. The primary goal is to encourage the adoption of modern manufacturing technologies.